Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for IV BuCy2 in chronic myelogenous leukemia

Borje S. Andersson, Peter F. Thall, Timothy Madden, Daniel Couriel, Xuemei Wang, Hai T. Tran, Paolo Anderlini, Marcos De Lima, James Gajewski, Richard E. Champlin

Research output: Contribution to journalArticlepeer-review

182 Scopus citations

Fingerprint

Dive into the research topics of 'Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for IV BuCy2 in chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences